SCHEMBL21275009

SCHEMBL21275009

CC(C)(C)OC(=O)N1[C@H](CN)CCC1(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 1/20 0.36
▸ CHRM1 P11229 1/20 0.36
▸ CHRM3 P20309 1/20 0.36
▸ CTSK P43235 1/20 0.35
▸ DDB1 Q16531 2/20 0.34
▸ CRBN Q96SW2 2/20 0.34
▸ SPHK1 Q9NYA1 1/20 0.34
▸ NR1H2 P55055 1/20 0.34
▸ HPGD P15428 1/20 0.33
▸ MAPT P10636 2/20 0.33
▸ HTT P42858 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ KDM1A O60341 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ RECQL P46063 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14239075 1.00 CHRM2 (0.36) CHRM2CHRM1CHRM3CTSKDDB1
SCHEMBL21244551 0.88 CHRM2 (0.35) CHRM2CHRM1CHRM3CTSKDDB1
SCHEMBL21274856 0.88 CHRM2 (0.35) CHRM2CHRM1CHRM3CTSKDDB1
SCHEMBL19959327 0.86 NR1H2 (0.41) CHRM2CHRM1CHRM3CTSKDDB1
SCHEMBL13606646 0.86 NR1H2 (0.41) CHRM2CHRM1CHRM3CTSKDDB1
SCHEMBL19637550 0.86 NR1H2 (0.41) CHRM2CHRM1CHRM3CTSKDDB1
SCHEMBL21245137 0.86 SPHK1 (0.34) CHRM2CHRM1CHRM3CTSKDDB1
SCHEMBL21275014 0.86 SPHK1 (0.34) CHRM2CHRM1CHRM3CTSKDDB1
SCHEMBL21274727 0.85 SPHK1 (0.34) CHRM2CHRM1CHRM3CTSKDDB1
SCHEMBL21244975 0.85 SPHK1 (0.34) CHRM2CHRM1CHRM3CTSKDDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3752510-A1 MACROCYCLES AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS THEREOF, THEIR USE IN THE TREATMENT OF CYCSTIC FIBROSIS, AND PROCESS FOR MAKING THEM Vertex Pharmaceuticals Incorporated (US) 2020-12-23 — — EP disclosed
WO-2019161078-A1 MACROCYCLES AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS THEREOF, THEIR USE IN THE TREATMENT OF CYCSTIC FIBROSIS, AND PROCESS FOR MAKING THEM VERTEX PHARMACEUTICALS INCORPORATED (US) 2019-08-22 — — WO disclosed
Send feedback